Capstone Investment Advisors’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-18,722	Closed	-$89.1K	–	1165
2023 Q2	$89.1K	Buy	+18,722	New	+$89.1K	﹤0.01%	787